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Abstract
Background: Periaqueductal gray (PAG) is the descending pain modulatory center, and PAG dysfunction had been
recognized in migraine. Here we propose to investigate altered PAG texture features (quantitative approach for
extracting texture descriptors for images) in the patients with medication-overuse headache (MOH) based on high
resolution brain structural image to understand the MOH pathogenesis.
Methods: The brain structural images were obtained from 32 normal controls (NC) and 44 MOH patients on 3.0 T
MR system. PAG template was created based on the ICBM152 gray matter template, and the individual PAG segment
was performed by applying the deformation field to the PAG template after structural image segment. Grey-level
co-occurrence matrix (GLCM) was performed to measure the texture parameters including angular second moment
(ASM), Contrast, Correlation, inverse difference moment (IDM) and Entropy.
Results: Contrast was increased in MOH patients (9.28 ± 3.11) compared with that in NC (7.94 ± 0.65) (P < 0.05), and
other texture features showed no significant difference between MOH and NC (P > 0.05). The area under the ROC curve
was 0.697 for Contrast in the distinction of MOH from NC, and the cut-off value of Contrast was 8.11 with sensitivity 70.
5% and specificity 62.5%. The contrast was negatively with the sleep scores (r = -0.434, P = 0.003).
Conclusion: Texture Contrast could be used to identify the altered MR imaging characteristics in MOH in understanding
the MOH pathogenesis, and it could also be considered as imaging biomarker in for MOH diagnosis.
Keywords: Brain, Magnetic resonance imaging, Medication-overuse headache, Migraine, Periaqueductal gray, Texture
analysis
Background
Periaqueductal gray (PAG) is a center with powerful
descending pain modulatory center in the midbrain,
which include various layered neurons around the aqua-
eductus mesencephali [1, 2], and whose dysfunction had
been recognized in migraine [3]. PAG, as a substantial
descending pain modulatory center, exerts inhibition
and facilitation control on nociceptive transmission in
the dorsal horn and trigeminal nucleus [4], and the
modulatory mechanism was exerted by descending
PAG-RVM (rostral ventromedial medulla) pathway
contributing to central sensitization and development of
secondary hyperalgesia [4, 5]. PAG included multiple
types of neurons (eg. L-glutamate,γ-aminobutyric acid
(GABA), opioids (particularly enkephalin), substance P),
and had distinct connections with the forebrain, brain-
stem, and nociceptive neurons of lamina I of the spinal
cord and trigeminal nucleus [6–9]. Therefore, PAG was
confirmed as a critical component of a network responsing
to pain and receiving functionally input from nociceptive
pathways [10–12].
In the previous studies, the specific PAG lesions had
been identified in multiple sclerosis [13–17] and infarction
[18], and nonspecific PAG lesions was also revealed in epi-
sodic migraine (EM) patients in our previous study [19].
The specific lesions was the direct evidence for migraine,
and the nonspecific lesions was indirectly used to explain
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the migraine pathogenesis, which may be associated
with iron deposition and may be considered as a pos-
sible "generator" of migraine attacks [1, 20, 21]. How-
ever, the neuromechinism for nonspecific PAG lesions
in migraine was still not elucidated up to now.
Medication-overuse headache (MOH) is a secondary
form of chronic headache deriving from episodic migraine
(EM) related to the overuse of triptans, analgesics and
other acute headache medications [22–24]. Resting-state
functional MRI (rs-fMRI) demonstrated altered functional
connectivity was revealed in MOH, and suggested that
MOH is associated with intrinsic brain network changes
rather with macrostructural changes [23]. Voxel-based
morphometry (VBM) recognized that increased gray mat-
ter in the midbrain presented in MOH [25]. Recently,
some studies also confirmed an altered nucleus accum-
bens functional connectivity of motivational circuits [22]
and abnormal connectivity between the PAG and other
pain modulatory (frontal) regions in MOH, which were
consistent with dysfunctional central pain control [26]. Al-
though the functional and structural MRI recognized the
PAG dysfunction in MOH patients, these methods did not
presented the detailed changes of the intrinsic natures of
PAG in MOH patients.
Texture features are the intrinsic properties of image
and provide an efficient image classification to detect sub-
tle alterations in the gray level distribution of an image
[27]. Texture feature analysis had been widely applied in
the brain tumor [28, 29], epilepsy [30, 31], muscular dys-
trophy [32], Attention-Deficit/Hyperactivity Disorder clas-
sification [33], and mild cognitive impairment [34].
However, MR imaging texture feature analysis was not ap-
plied in medication-overuse headache (MOH) so far.
In this study, we hypothesize MOH patients without T2-
visible lesions may present altered texture features changes
in MR structural images. To address this hypothesis, we
prospectively obtained high resolution structural images
from 44 MOH patients and 32 NCs without T2-visible le-
sions on the brain. Gray level co-occurrence matrix(GLCM)
[35, 36] was used to calculate the texture parameters of
PAG including angular second moment (ASM), Contrast,
Correlation, inverse difference moment (IDM) and Entropy
in the subjects, which would be used to detect the texture
features change for PAG to elucidate the neuromechnism of
PAG dysfunction in MOH pathogenesis.
Methods
Subjects
Written informed consent was obtained from all partici-
pants according to the approval of the ethics committee of
the local institutional review board. Forty-four MOH pa-
tients and 32 normal controls were recruited from the
International Headache Center, Department of Neurology,
Chinese PLA General Hospital. All the following inclusion
criteria should be fulfilled: 1) MOH refers to ICHD-III beta
8.2, and the definition of migraine refers to ICHD-III beta
1.1 and 1.2 [37]; 2) no migraine preventive medication used
in the past 3 months; 3) age between 20 and 60 years; 4)
right-handed; 5) absence of any chronic disorders, including
hypertension, hypercholesterolemia, diabetes mellitus, car-
diovascular diseases, cerebrovascular disorders, neoplastic
diseases, infectious diseases, connective tissue diseases,
other subtypes of headache, chronic pain other than head-
ache, severe anxiety or depression preceding the onset of
headache, psychiatric diseases, etc.; 6) absence of alcohol,
nicotine, or other substance abuse; and 7) patient’s willing-
ness to engage in the study. Thirty-two normal controls
(NCs) were recruited from the hospital’s staff and their
relatives. Inclusion criteria were similar to those of pa-
tients, except for the first two items, and NCs should
never have had any primary headache disorders or other
types of headache in the past year. The exclusion criteria
for NC and MOH were the following: cranium trauma, ill-
ness interfering with central nervous system function,
psychotic disorder, and regular use of a psychoactive or
hormone medication. General demographic and headache
information were registered and evaluated in our head-
ache database. Additionally, we evaluated anxiety, depres-
sion, and cognitive function of all the participants by
using the Hamilton Anxiety Scale (HAMA) [38], the
Hamilton Depression Scale (HAMD) [39], and the
Montreal Cognitive Assessment (MoCA) Beijing Ver-
sion (www.mocatest.org). All the patients were given
with the Visual Analogue Scale (VAS), migraine dis-
ability assessment (MIDSA), and a standard categor-
ical four-grade sleep disturbance scale (SDS)(0,
normal; 1, mild sleep disturbance; 2, moderate sleep
disturbance; 3, serious sleep disturbance). MRI scans
were taken in the interictal stage at least three days
after a migraine attack for MOH patients. All the
subjects were right-handed and underwent conven-
tional MRI examination to exclude the subjects with
cerebral infarction, malacia, or occupying lesions. Al-
cohol, nicotine, caffeine, and other substances were
avoided for at least 12 h before MRI examination.
MRI acquisition
Images were acquired on a GE 3.0 T MR system
(DISCOVERY MR750, GE Healthcare, Milwaukee, WI,
USA) and a conventional eight-channel quadrature
head coil was used. All subjects were instructed to lie in a
supine position, and formed padding was used to limit
head movement. A three-dimensional T1-weighted fast
spoiled gradient recalled echo (3D T1-FSPGR) sequence
generating 180 contiguous axial slices [TR (repetition
time) = 6.3 ms, TE (echo time) = 2.8 ms, flip angle = 15°,
FOV (field of view) = 25.6 cm× 25.6 cm, Matrix = 256 ×
256, NEX (number of acquisition) = 1] was used to perform
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the new segment and the individual PAG creation. Conven-
tional T2-weighted imaging (T2WI), T1 fluid-attenuated
inversion recovery (T1-FLAIR) and diffusion weighted
imaging (DWI) were also acquired. All imaging protocols
were identical for all subjects. No obvious structural dam-
age and T2-visible lesion were observed on the conven-
tional MR images.
MR image processing
All MR structural image data were processed using
Statistical Parametric Mapping 12 (SPM12) (http://
www.fil.ion.ucl.ac.uk/spm/) running under MATLAB
7.6 (The Mathworks, Natick, MA, USA) to perform seg-
ment [40]. The image processing included following steps:
(1) Create PAG template based on mni_icbm152_gm_-
tal_nlin_asym_09a template using MRIcron software
(http://people.cas.sc.edu/rorden/mricron/index.html); (2)
The structural images segment were performed with the
new segment tool of SPM12 software, and the deform-
ation field(iy_subjectid.nii) was generated. (3) Individual
PAG mask (wPAG.nii) was generated by apply the
deformation field (generated by new segment) to the PAG
template using deformations tool of SPM12 software; (4)
The individual PAG(wPAG_AddMask.nii) were seg-
mented by an in-house script written on MATLAB (the
Math Works, Inc., Natick, MA, USA) platform. The in-
house script was provided in the in Additional file 1. (5)
The PAG texture parameters were calculated over the
whole PAG using gray-level co-occurrence matrix(GLCM)
with the GLCM plugins on ImagJ(1.50i)(https://imagej
.nih.gov/ij). The texture parameters included ASM,
Contrast, Correlation, IDM and Entropy [35, 41] (Fig. 1).
These texture parameters were measured on each slice,
and the mean texture parameters values over all the slices
were regarded as the final texture parameter value.
Statistical analysis
The statistical analysis was performed by using PASW
Statistics 18.0. Independent sample T test was applied to
age, HAMA, HAMD, MoCA scores and all the texture
parameters. Chi-Square test was applied to sex. Pearson
correlation analysis was applied between Contrast and
the clinical variables. Significant difference was set at a P
value of < 0.05. Receiver operating characteristics (ROC)
curve analysis was applied to evaluate the diagnostic effi-
cacy of Contrast.
Results
Demography and neuropsychological test
There was no significant difference for age and sex be-
tween MOH and NC, a significant difference for HAMA
between MOH(18.25 ± 8.74) and NC (10.19 ± 2.98),
HAMD between MOH (19.80 ± 11.85) and NC (8.03 ±
4.34), MoCA among MOH (23.43 ± 3.72) and NC (27.16
± 2.32) (Table 1).
Comparison of PAG texture parameters between MOH
and NC
Table 2 demonstrated that there was a significant
increased Contrast in MOH (9.28 ± 3.11) compared with
that in NC (7.94 ± 0.65)(P < 0.05). The ASM, Correlation,
Fig. 1 The flowchart of PAG texture calculation. GLCM, grey-level co-occurrence matrix; ASM, Angular Second Moment; IDM, Inverse Difference Moment
Table 1 The clinical characteristics of normal controls and MOH
patients
NC MOH T value P value
Sex(M/F) 32(12/20) 44(9/35) 2.692a 0.101
Age(year) 41.34 ± 10.89 42.30 ± 9.62 0.403 0.688
HAMA 10.19 ± 2.98 18.25 ± 8.74 5.002 0.000
HAMD 8.03 ± 4.34 19.80 ± 11.85 5.354 0.000
MoCA 27.16 ± 2.32 23.43 ± 3.72 4.999 0.000
DD(year) 11.25 ± 9.30
VAS 7.88 ± 1.45
MIDSA 101.81 ± 53.95
Frequence(month) 24.81 ± 6.32
SDS 2.23 ± 1.36
aChi-Square test; NC normal control, MOH medication-overuse headache, DD
disease duration, VAS visual analogue scale; HAMA Hamilton Anxiety Scale,
HAMD Hamilton Depression Scale, MoCA Montreal Cognitive Assessment, NA
not available, SDS standard categorical four-grade sleep disturbance scale (0,
normal; 1, mild sleep disturbance; 2, moderate sleep disturbance; 3, serious
sleep disturbance)
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IDM and Entropy showed no significant difference be-
tween MOH and NC. Figure 2 presented the distribution
of increased Contrast in MOH patients, and the other
texture parameters showed no significant change in
MOH patients compared with NC patients.
ROC curve analysis and correlation analysis for Contrast
ROC analysis demonstrated that area under curve
(AUC) of Contrast was 0.697 in NC vs. MOH, and the
cut-off value was 8.11 with sensitivity 70.5% and specifi-
city 62.5% (Fig. 3). The contrast was negatively with the
SDS scores (r = -0.434, P = 0.003), and presented no sig-
nificant correlation with other clinical variables.
Discussion
GLCM has proved to be a popular statistical method of
extracting textural feature from MR images. In this study,
five texture features were extracted, and previous study rec-
ognized that ASM represented the image energy, IDM rep-
resented the local homogeneity, Entropy represented the
amount of information of the image that is needed for the
image compression, and Correlation represented the linear
dependency of grey levels of neighboring pixels [42]. In the
current study, these four texture features did not showed
significant difference between MOH patients and NCs,
which suggested these four texture features could not eluci-
date the MOH pathogenesis, and they were not considered
as diagnostic variables.
Contrast represents the amount of local gray level vari-
ation in an image, and a high value high value of this par-
ameter may indicate the presence of noise or “wrinkled”
textures in the image [30]. In this study, the increased
Contrast texture parameter was identified in MOH
patients, which suggested that PAG present increased
local gray level variation in MR T1 images. The increased
noise in PAG image may be associated with local hetero-
geneous intensity, which may be influenced by the iron
deposition [20, 21] or other factors, and the neurome-
chanism should be further investigated.
Further ROC analysis revealed that AUC was 0.697 for
Contrast, and the cut-off value (8.11) presented with sen-
sitivity 70.5% and specificity 62.5%, which indicated that
Contrast might be consider as an imaging biomarker for
the diagnosis of MOH. Correlation analysis demonstrated
that Contrast was negatively related to SDS scores, which
indicated that decreased sleep quality was associated with
the MOH pathogenesis. And other clinical variables
showed no any correlation with Contrast, and these find-
ings demonstrated that neuropsychological factors and
pain intensity may be not associated with the PAG dys-
function in MOH pathogenesis.
In this study, GLCM method was used to calculate the
MR image texture features on MOH patients, and texture
Contrast was screened from the five texture parameters to
explain the PAG dysfunction in MOH patients. However,
there were several limitations in our study. Firstly, this study
was based on GLCM method to calculate the texture fea-
tures of PAG, and the other novel texture analysis methods
such as histogram analysis and first order texture analysis
should be considered in the future. Secondly, only five tex-
ture features were calculated in this study, and more texture
features should be measured to screen the significant tex-
ture features for MOH patients. Lastly, 3D high resolution
structural image was used to calculate the PAG texture fea-
tures because of its high contrast for PAG, and the other
MR images such as T2 weighted image and susceptibility
Table 2 Comparison of PAG texture parameters among NC and MOH
NC MOH T value P value
ASM(×10-3) 0.998768 ± 0.000124 0.998709 ± 0.000175 1.656 0.102
Contrast 7.943417 ± 0.645233 9.282469 ± 3.109250992 2.395 0.019
Correlation 0.06879277 ± 0.01808873 0.062252806 ± 0.030849871 1.072 0.287
IDM(×10-3) 0.999345 ± 0.000051 0.999331992 ± 0.0000595448 1.007 0.317
Entropy(×10-5) 0.008454 ± 0.000705 0.008718528 ± 0.00096365 1.317 0.192
ASM Angular Second Moment, IDM Inverse Difference Moment
Fig. 2 Comparison of PAG texture between MOH and NC, and the significant difference of Contrast presented in MOH compared with NC
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weighted image should also be considered for the texture
analysis in the future.
Conclusion
In conclusion, this study revealed that altered PAG texture
Contrast presented in MOH patients undetected by visual
assessment, and it may be associated with PAG dysfunc-
tion and may be considered as a auxiliary diagnostic and
evaluated imaging biomarker in MOH patients.
Additional file
Additional file 1: The in-house script written on MATLAB (the Math
Works, Inc., Natick, MA, USA) platform was used to segment individual
PAG. (DOC 22 kb)
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